Tagged head

ArmorSource Introduces Next Generation Aire System
Press Release

ArmorSource Introduces Next Generation Aire System

 Read More
Study Investigates New Approach to Diagnosis and Treatment of Head and Neck Cancers
Press Release

Study Investigates New Approach to Diagnosis and Treatment of Head and Neck Cancers

 Read More
DRI and 6D Helmets Win NFL's Head Health Challenge III
Press Release

DRI and 6D Helmets Win NFL's Head Health Challenge III

 Read More
Press Release

Otto's Shrunken Head Presents "A Night of Roots-Punk Ruckus"

 Otto's Shrunken Head presents the special showcase, "A Night of Roots-Punk Ruckus". Read More
Press Release

Otto's Shrunken Head Presents "Darren Deicide Rings in Ragnarok"

 Otto's Shrunken Head and Darren Deicide join to present a special show commemorating the symbolic rise of Ragnarok. The show will take place Saturday, February 22nd at New York City's own Tiki bar and original music venue, Otto's Shrunken Head. Read More
Press Release

Love & Death Featuring Former Korn Guitarist Brian "Head" Welch To Release Chemicals EP Today

 Love And Death, the new band led by former Korn guitarist Brian Head Welch, is releasing their new EP today. Read More
Press Release

DREAM CITY PHOTO Did Anthony Carrs 4-Pic Headshot To Showcase His Brilliant Talent In The Industry

 Dream City Photo, a full-service digital photo lab that caters to the entertainment industry has recently done Anthony Carr's 4-pic headshot to showcase his brilliant talent in the industry. Read More
Press Release

Oncolytics Biotech® Inc. Collaborators Present Data from U.K. Translational Colorectal Cancer Study at the International Symposium

 The researchers concluded that reovirus can be successfully delivered specifically to colorectal liver metastases following intravenous administration as a monotherapy and that pre-operative treatment was safe. Read More
Press Release

Oncolytics Biotech® Inc. Receives No Objection Letter from Health Canada to Conduct Phase 3 Trial of REOLYSIN® in Head and Neck Cancers

 Oncolytics Biotech Inc announced that it has received a No Objection Letter from Health Canada to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin. Read More